Treace Presents New Product Innovations at ACFAS 2022 Scientific Conference
PONTE VEDRA, Fla., Feb. 23. 11, 2022 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a commercial-stage orthopedic medical device company leading a paradigm shift in the surgical treatment of hallux valgus ( commonly referred to as bunions) through its Lapiplasty® 3D Bunion Correction™ procedure, announces that it will highlight new product innovations at the 2022 American College of Foot and Ankle Surgeons (ACFAS) Annual Scientific Conference in Austin, in Texas, from February 24 to 27.
Several new technologies will be presented at the Treace Medical exhibition (booth n° 322) during the ACFAS conference:
Lapiplasty® 3-n-1™ Guide: The 3-n-1™ Guide is an advanced instrument specifically developed as part of efforts to continuously advance the speed and reproducibility of the Lapiplasty® 3D Bunion Correction™ procedure. The 3-n-1™ Guide combines multiple devices into one precision instrument and is designed to reduce surgical time and increase efficiency in the deformity realignment and joint preparation stages of the Lapiplasty® procedure.
Extension of the Adductoplasty™ system: The full commercial deployment of the Adductoplasty™ Midfoot Correction System adds several specialized instruments designed to improve efficiency and expand the clinical applications of the system. The expanded Adductoplasty™ System now provides an integrated solution of instruments and implants specifically designed to treat a variety of midfoot pathologies, including arthritis of the lower tarso-metatarsal joints and metatarsal adductus (MTA), a midfoot deformity that occurs in about 30% of bunion patients1 and may lead to an increased risk of bunion recurrence if the MTA deformity is not treated at the same time as the bunion correction procedure.2.3
Lapiplasty® S4A Anatomic Veneer System: The S4A System represents the next generation of Lapiplasty® titanium plate fixation technology, providing foot and ankle surgeons with an additional fixation option for the Lapiplasty® 3D Bunion Correction™ procedure. Based on anatomical studies of the first tarsometatarsal joint, the S4A anatomical plates feature an advanced three-dimensional contour designed to better accommodate certain anatomical variabilities of the medial cuneiform bone.
SpeedRelease™ and TriTome™ Release Instruments: These new single-use specialty cutting instruments are designed to provide more reliable and complete surgical release of major soft tissue structures commonly treated during Lapiplasty® and Adductoplasty™ procedures.
John T. Treace, CEO, Founder and Member of the Board of Directors of Treace, said, “As the only company in the industry focused exclusively on bunion correction, we are thrilled to present our latest R&D innovations to surgeons attending the ACFAS 2022 conference. These new technologies demonstrate Treace’s commitment to rapid innovation with a focus on continuous improvement of both the surgeon’s experience with our products and the clinical outcomes of its patients.
About Treace Medical Concepts
Treace Medical Concepts, Inc. is a commercial-stage orthopedic medical device company focused on advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex three-dimensional deformities that originate from an unstable joint in the midfoot. Treace pioneered and patented the Lapiplasty® 3D Bunion Correction™ System – a combination of instruments, implants and surgical methods designed to correct all 3 planes of the bunion deformity and secure the unstable joint, attacking the root cause of bunion and helping patients get back to their active lifestyle. Treace recently expanded its offering with the Adductoplasty™ midfoot correction system, designed for reproducible midfoot correction that could provide additional support for patients with hallux valgus. For more information, please visit www.treace.com.
About the ACFAS Scientific Conference
The American College of Foot and Ankle Surgeons (ACFAS) is a professional society of more than 7,800 foot and ankle surgeons. The ACFAS Annual Scientific Conference is an educational event bringing together foot and ankle surgeons from around the world.
1. Ayyer AA, et al. Foot Ankle Int. 2014 ; 35:1292-1297.
2. Ayer A, et al. Foot Ankle Int. 2016; 37:165-171.
3. Park CH, Lee W. J Bone Joint Surg Am. 2017; 1190-1197.
Tracee Medical Concepts
Lynn Lewis or Vivian Cervantes